3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
18
Breast Neoplasms
16
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myeloid, Acute
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Recurrence
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Glioblastoma
2
Genetic Predisposition to Disease
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Interventions
Temozolomide
1
Specimen Handling
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Etoposide
1
Cisplatin
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Somatostatinoma
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.